The company launched the A303 Stonehenge business directory in December, extending an invite for small and medium-sized businesses to get involved in the transformational dualling scheme and tunnel project, and in less than two months a total of 161 companies are now registered – half of those from the Wiltshire locality.

A virtual Meet the Buyer event was held on 21 January, in which more than 130 people heard from Highways England’s project team and preliminary works contractors Wessex Archaeology Ltd and Osborne Ltd, about upcoming opportunities to play a part in the scheme.

The virtual event was the first in a series of engagement activities planned with local and regional SMEs ahead of fieldwork and preliminary works starting later this year.

David Bullock, Highways England Project Manager for the A303 Stonehenge scheme, said:

We’re delighted by the response so far, and we’d like to see that number double again in the coming weeks to enable local and regional SMEs to gain access to business opportunities within the scheme.

We need businesses large and small to help build the scheme, but we understand that small and medium-sized enterprises face challenges in getting a foot in the door on projects of this scale, so we want to break down any barriers by standardising terms and conditions, minimising requirements and applying a fair and prompt payment initiative.

The project has numerous benefits, not only in improving journey reliability and enhancing the World Heritage Site landscape, but also in unlocking economic growth in the South West.

The preliminary work will provide initial opportunities within the next six months or so with greater potential for SMEs ahead, once Highways England appoints its main contractor later this year, or early 2022.

Highways England is already working closely with the Swindon and Wiltshire Local Enterprise Partnership, Business West, the Federation of Small Businesses, Salisbury and District Chamber of Commerce and Salisbury BID, and has also partnered nationally with the Supply Chain Sustainability School to provide free online training.

This helps smaller companies to upskill and places them in a better position to tender for work on larger infrastructure projects, such as the A303 Stonehenge upgrade.

Deborah Fraser, South West Director of the CBI (Confederation of British Industry), said:

Upgrades to the full A303/A30/A358 corridor will drastically improve connectivity between the South West and the rest of the country, and open new doors for businesses in advanced manufacturing, low carbon and digital technologies, and tourism and hospitality.

Those new opportunities begin with the construction phase, and it’s encouraging to see so many local SMEs expressing an interest in lending their expertise to this transformative project.

At a time when so many businesses are worried about their future, these works can inject fresh optimism in the South West and boost regional productivity, while delivering tangible proof that the government is serious about fulfilling its levelling up pledges across the country.

Of the companies registered so far, a large percentage are involved in civil engineering, building and civil works, security, facilities management and landscaping, together with other professional services such as business supply, catering, cleaning, environmental and waste management.

Robin Trevett of Salisbury and District Chamber of Commerce said:

A project such as this presents a host of opportunities for local business, something both the Salisbury and District Chamber of Commerce and Salisbury Business Improvement District fully support.

We look forward to seeing future events as the project develops and ultimately, the opportunity for our members to play their part in this major project.

Businesses interested in being a part of the A303 Stonehenge project are urged to register their details. Information will then be passed to the relevant contractors.

Highways England has recently unveiled its ambition for the A303 Stonehenge project through the voices of the people it touches most, including businesses and local communities. The visionary video can be seen here:

visionary video

For more details and updates on the A303 Stonehenge scheme website, people can log on to the scheme website, and for any further queries, companies can email info@a303stonehenge.co.uk

General enquiries

Members of the public should contact the Highways England customer contact centre on 0300 123 5000.

Media enquiries

Journalists should contact the Highways England press office on 0844 693 1448 and use the menu to speak to the most appropriate press officer.

The Centre for Data Ethics and Innovation (CDEI), the UK government’s advisory body on the responsible use of AI and data-driven technology, has published new analysis on the use of data in local government during the COVID-19 crisis. It draws on findings from a forum attended by local authorities across the country, in which they explored changes to data use during the pandemic and discussed barriers to data-driven innovation, as well as new research into public attitudes towards local data use. Key findings include:

• The COVID-19 crisis has accelerated the innovative use of data at a local level, with a range of data-driven interventions launched or repurposed during the pandemic. Examples include: the use of the ‘VIPER’ tool by local authorities in Essex, which has enabled emergency services to share data in real time; Argyll and Bute Council’s trial of drone technology to deliver vital medical supplies across its islands; Glasgow City Council’s online platform to promote social distancing; and Hackney Council’s analysis of internal and external datasets to help them identify residents who are vulnerable to COVID-19.
• Health data has been shared with local authorities in new ways. For example, local authorities have received access to the NHS shielding patients database, allowing authorities to better target support, including food parcels and pharmacy deliveries, to vulnerable individuals.
• Authorities have had more success in changing how they deploy existing datasets than in acquiring or sharing data with central government or local service providers.
• For sustainable adoption, the governance of new technologies needs to be informed by engagement with local citizens to ensure that it is trustworthy. New polling shows that 50% of people want to engage with their local authority on how data is used to make decisions.

Representatives convened by the CDEI expressed concerns that progress would not be sustained, with data use practices reverting to the pre-pandemic status quo. Reasons for this include: uncertainty around whether emergency access to datasets will be repealed; enthusiasm for data-driven interventions among decision-makers waning; fear of misjudging the public mood on what is an acceptable use of data; and reluctance among local authorities to be a “first mover” in what is perceived to be a high risk environment. Local authorities are also grappling with long-standing barriers to data-driven innovation, including skills gaps, poor data quality, lack of legal clarity and funding challenges.

The CDEI warns that progress is unlikely to be made without dedicated action from central and local government. Whilst encouraging, recent steps forward, such as the publication of the Local Government Association’s guide to predictive analytics, and the Ministry of Housing, Communities and Local Government’s COVID-19 challenge fund, are unlikely to move the needle on their own. Without increased investment and an improvement in data skills, local authorities will struggle to retain and build on recent progress. In its National Data Strategy, the government has outlined an ambition to strengthen skills, improve access to data, and offer greater regulatory clarity, and has committed to working to better support local government in maximising the benefits of data.

While conversations have already started on what practices should be retained post-pandemic, the CDEI’s forum pushed thinking further by focusing on the importance of good data governance in enabling trustworthy data use. While responsible data governance was top of mind for data leads, they commented on the difficulty of translating theoretical frameworks into practical steps.

The CDEI has also researched public attitudes towards the use of data in local government, and the results suggest that citizens want a stake in how their data is used. In the representative sample of 2,025 people, conducted with Deltapoll, 50% reported interest in engaging with their local authority on how data is used to make decisions. Levels of understanding around how local authorities use data is extremely varied: 39% said that they did not know if their personal data is being collected or how it is being used.

The results suggest that the public are more comfortable with data collection and use by their local authority if context is provided. When given specific scenarios, such as the use of data to identify children who might be at risk of domestic violence, the proportion of people who felt comfortable was higher than when asked about the collection and use of raw data (e.g. education data). Those polled felt that the greatest benefit of data use would be improvements to their local community (31%). When asked about measures that would enable trust in local council use of data, the two most popular responses were data anonymisation (24%) and strict access and use controls (23%).

The CDEI is now working in partnership with local authorities, including Bristol City Council, to help them maximise the benefits of data and data-driven technologies, by building trustworthy governance that earns the confidence of citizens over the long-term.

Edwina Dunn, Board member for the Centre for Data Ethics and Innovation, said : “Almost every aspect of local government has required at least temporary reform during the pandemic. Data and data-driven technologies have played an important part in enabling local authorities to respond to the COVID-19 crisis, helping to inform public health measures, protect the most vulnerable in local communities, and keep public services running. With the right support, councils can retain and build on efforts to utilise data effectively, in a way that is in keeping with the expectations of their residents, to provide local services communities can rely on. The CDEI is looking forward to continuing to work with the government, as well as with local authorities and other relevant stakeholders, on this important agenda.”

John Whittingdale, Minister of State for Media and Data at the Department for Digital, Culture, Media and Sport, said: “Local authorities have gone above and beyond in supporting their communities during the pandemic, and data has been at the heart of some key interventions that have helped the most vulnerable. This government is committed to maintaining the high watermark of data use set during the pandemic, and we recognise the opportunities that data presents to drive better delivery of public services. Through our National Data Strategy, we are committed to working with local government partners to better understand the barriers they face in utilising data to its fullest potential, and this report will be a useful input in identifying how to do so effectively.”

Luke Hall, Minister for Regional Growth and Local Government at the Ministry of Housing, Communities and Local Government, said: “Councils and council workers have been at the forefront of the response to the pandemic, helping to keep their communities safe, while ensuring essential services have continued throughout. From delivering food parcels, medicines and support to clinically extremely vulnerable individuals to housing rough sleepers quickly, the use of data has been critical. Councils have adapted their services from in-person to online, using technology and data to do so lawfully and securely, and I am determined we continue to use everything we have learned to make services better for residents so that local communities keep benefitting from more efficient public services.”

James Jamieson, Chair of the Local Government Association, said: “The use of data is one of many factors that councils may consider as part of their decision-making processes. We’re pleased to be working with the Centre for Data Ethics and Innovation to bring together councils from across the country so they can share best practice in this area and be as transparent as possible. The good and ethical use of data will help councils support their communities through the pandemic and into the future.”

Ends

Contacts

Pippa Hardingham 07827 802 325 pippa.hardingham@cdei.gov.uk

Jessica Bancroft 07831 166 111 jessica.bancroft@cdei.gov.uk

Notes to Editor

• The CDEI was set up in 2018 to advise on the governance of AI and data-driven technology. The Centre is overseen by an independent Board, made up of experts from across industry, civil society, academia and government.
• The report draws together the findings of a forum discussion hosted with data and information governance leads from local authorities, and is supplemented by individual interviews and desk research, as well as new research into public attitudes towards local data use.
• The discussion is one of a series of AI Forums hosted by the CDEI, in which a range of experts are invited to discuss the most pressing issues relating to data-driven technology.
• The CDEI has been collating examples of novel use-cases of AI and data specifically being used to counter and mitigate the effects of the pandemic in its COVID-19 repository. The CDEI produced a local government edition of this repository, which revealed an eclectic range of interventions by local authorities.
• The CDEI published a report on public sector data sharing in 2020. It involved a detailed analysis of projects where data had been shared between government departments, and with commercial organisations, identifying recurring barriers, and the steps that were taken to address them. The report focused on citizen trust, arguing that it needs to be addressed if we are to maximise the value of data held. It included a framework to drive forward trustworthy data sharing in the public interest. The CDEI is working in partnership with other organisations, including Bristol City Council, to apply, test and revise the framework in different contexts.
• As part of the CDEI’s review into bias in algorithmic decision-making, the CDEI considered the use of algorithms in local government. It argued that data-driven tools present opportunities for local government, but cautioned that they should not be considered a silver bullet for funding challenges. Moreover, it found that data infrastructure and data quality were significant barriers to developing and deploying data-driven tools effectively and responsibly, arguing that investment in this area is needed before developing more advanced systems.
• Engaging with the public has been a core component of the CDEI’s work since formation. It recently announced that it is stepping up its public engagement efforts to ensure that its advice is grounded in a deep understanding of public attitudes towards data-driven technologies, as well as of the values that citizens want reflected in new models of data governance.
• On behalf of the CDEI, Deltapoll interviewed 2,025 UK adults online between 10th-17th December 2020. The data have been weighted to be representative of the UK adult population as a whole.
• As part of the UK government’s consultation on the National Data Strategy, which ran from 9th September 2020-9th December 2020, DCMS consulted on the CDEI’s proposed future functions, as well as whether a statutory status would help the CDEI to deliver its remit. DCMS is currently analysing the feedback it received and will publish the outcome in due course.

• Clinical trial looking into alternating COVID-19 vaccine doses launched today in the UK
• Current programme of 2 doses of the same vaccine over 12 weeks remains unchanged
• Innovative study backed by £7 million of government funding

Patients taking part in a new clinical study launching today will soon receive different COVID-19 vaccines for their first or second dose.

Backed by £7 million of government funding, the study will be the first in the world to determine the effects of using different vaccines for the first and second dose – for example, using Oxford University/AstraZeneca’s vaccine for the first dose, followed by Pfizer/BioNTech’s vaccine for the second.

The study, run by the National Immunisation Schedule Evaluation Consortium (NISEC) across 8 National Institute for Health Research (NIHR) supported sites, will also gather immunological evidence on different intervals between the first and second dose for a mixed-vaccine regimen against control groups when the same vaccine is used for both doses.

A same-dose regimen is currently implemented for the national COVID-19 vaccination programme, and there are no current plans for this to change. Anyone who has received either the Pfizer or AstraZeneca vaccination as part of the UK-wide delivery plan will not be affected by this study. They will receive their second dose from the same source and over the same 12-week interval.

The 13-month study will monitor the impact of the different dosing regimens on patients’ immune responses, which have the potential to be higher or lower than from the same dose regimen. Initial findings are expected to be released in the summer. The study has received ethics approval from the Research Ethics Committee, as well as approval from the Medicines and Healthcare products Regulatory Agency (MHRA).

Should the study show promising results, then the government may consider reviewing the vaccine regimen approach if needed, but only if proven to be safe and recommended by the Joint Committee on Vaccination and Immunisation (JCVI).

Minister for COVID-19 Vaccine Deployment, Nadhim Zahawi, said:

This is a hugely important clinical trial that will provide us with more vital evidence on the safety of these vaccines when used in different ways.

Nothing will be approved for use more widely than the study, or as part of our vaccine deployment programme, until researchers and the regulator are absolutely confident the approach is safe and effective.

This is another great step forwards for British science, expertise and innovation, backed by government funding – and I look forward to seeing what it produces.

Deputy Chief Medical Officer and Senior Responsible Officer for the study, Professor Jonathan Van-Tam, said:

Given the inevitable challenges of immunising large numbers of the population against COVID-19 and potential global supply constraints, there are definite advantages to having data that could support a more flexible immunisation programme, if needed and if approved by the medicines regulator.

It is also even possible that by combining vaccines, the immune response could be enhanced giving even higher antibody levels that last longer; unless this is evaluated in a clinical trial we just won’t know.

This study will give us greater insight into how we can use vaccines to stay on top of this nasty disease.

The study will initially have 8 different arms testing 8 different combinations, but more products may be added. The 8 arms include:

• 2 doses of the Oxford/AstraZeneca vaccine at 28 days apart
• 2 doses of the Oxford/AstraZeneca vaccine at 12 weeks apart – as a control group
• 2 doses of the Pfizer/BioNTech vaccine at 28 days apart
• 2 doses of the Pfizer/BioNTech vaccine at 12 weeks apart – as a control group
• the Oxford/AstraZeneca vaccine for the first dose, followed by the Pfizer/BioNTech vaccine for the second, at 28 days apart
• the Oxford/AstraZeneca vaccine for the first dose, followed by the Pfizer/BioNTech vaccine for the second, at 12 weeks apart
• the Pfizer/BioNTech vaccine for the first dose, followed by the Oxford/AstraZeneca vaccine for the second, at 28 days apart
• the Pfizer/BioNTech vaccine for the first dose, followed by the Oxford/AstraZeneca vaccine for the second, at 12 weeks apart

Over 800 patients are expected to take part in the study, referred to as the COVID-19 Heterologous Prime Boost study or ‘Com-Cov’, across 8 different sites across England – including in London, Birmingham and Liverpool.

Patients will be recruited over the course of February via the NHS COVID-19 Vaccine Research Registry, with vaccinations expected to start towards the middle of the month and initial results to be made available over the summer period. The UK public can volunteer to be contacted about taking part in the study and further vaccine studies by joining the registry.

The study has been classified as an Urgent Public Health study by the NIHR and is being undertaken by NISEC and the Oxford Vaccine Group, with funding of £7 million from the government through the Vaccines Taskforce.

Chief Investigator Matthew Snape, Associate Professor in Paediatrics and Vaccinology at the University of Oxford, said:

This is a tremendously exciting study that will provide information vital to the roll out of vaccines in the UK and globally. We call on those aged 50 years and above who have not yet received a COVID-19 vaccine to visit our website to find out more about the study and see if there is a study site near them.

If we do show that these vaccines can be used interchangeably in the same schedule this will greatly increase the flexibility of vaccine delivery, and could provide clues as to how to increase the breadth of protection against new virus strains.

National Clinical Lead for the NIHR COVID Vaccine Research Programme, Professor Andrew Ustianowski, said:

This is another exciting step forward in finding a variety of vaccine options for the UK and globally, for which the NIHR is integral to ensuring the participant recruitment for this study and the gaining of robust data on safety and effectiveness.  

We need people from all backgrounds to take part in this trial, so that we can ensure we have vaccine options suitable for all. Signing up to volunteer for vaccine studies is quick and easy via the NHS Vaccine Research Registry.

Interim Chair of the government’s Vaccines Taskforce, Clive Dix, said: 

Thanks to funding from the Vaccines Taskforce, this study will give us valuable insight into how vaccines work together and could give us more flexibility as we continue to tackle this virus in the weeks, months and years ahead.

This is yet another example of the UK leading the way in vital research into COVID-19 – and something that people both in this country, and around the world, could benefit from.

Volunteers for the study can sign up on the NHS website

This study is separate to the COVID-19 national immunisation programme. Vaccines are not being mixed as part of rollout of the national COVID-19 immunisation programme.

The trial sites include:

• London – St George’s and UCL
• Oxford
• Southampton
• Birmingham
• Bristol
• Nottingham
• Liverpool

The Vaccines Taskforce was set up under the Department for Business, Energy and Industrial Strategy (BEIS) in May 2020, to ensure that the UK population has access to clinically effective and safe vaccines as soon as possible, while working with partners to support international access to successful vaccines. This is to place the UK at the forefront of global vaccine research, development, manufacture and distribution.

The Vaccines Taskforce comprises a dedicated team of private sector industry professionals and officials from across government who are working at speed to build a portfolio of promising vaccine candidates that can end the global pandemic.

The Vaccines Taskforce’s approach to securing access to vaccines is through:

• procuring the rights to a diverse range of promising vaccine candidates to spread risk and optimise chances for success
• providing funding for clinical studies, diagnostic monitoring and regulatory support to rapidly evaluate vaccines for safety and efficacy
• providing funding and support for manufacturing scale-up and fill and finish at risk so that the UK has vaccines produced at scale and ready for administration should any of these prove successful

Through the Vaccines Taskforce, the UK has secured early access to 407 million doses of 7 of the most promising vaccines so far. To date, the government has invested over £300 million into manufacturing a successful vaccine. In the Chancellor’s Spending Review, published on 25 November, it was announced that the government has made more than £6 billion available to develop and procure successful vaccines.

Oxford University has been placed number one in the Times Higher Education World University Rankings for the fifth year running, and at the heart of this success is our ground-breaking research and innovation. 

Oxford is world-famous for research excellence and home to some of the most talented people from across the globe. Our work helps the lives of millions, solving real-world problems through a huge network of partnerships and collaborations. The breadth and interdisciplinary nature of our research sparks imaginative and inventive insights and solutions. 

Through its research commercialisation arm, Oxford University Innovation, Oxford is the highest university patent filer in the UK and is ranked first in the UK for university spinouts, having created more than 200 new companies since 1988. Over a third of these companies have been created in the past 3 years.